World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
40071
World Ranking
7050
National Ranking
75

Anthony T.C. Chan publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Anthony T.C. Chan sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 503 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Anthony T.C. Chan D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Anthony T.C. Chan sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 104 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Anthony T.C. Chan is affiliated with the Chinese University of Hong Kong in China. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a notable focus on Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology, Surgery, and Molecular Biology.

Their scientific work addresses multiple specialized topics, including:

  • Head and Neck Cancer Studies
  • Viral-associated cancers and disorders
  • Advanced Radiotherapy Techniques
  • Lung Cancer Treatments and Mutations
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cancer Immunotherapy and Biomarkers
  • Radiation Therapy and Dosimetry

Among recent publications, notable papers include:

  • "Nasopharyngeal carcinoma: an evolving paradigm" (2021), published in Nature Reviews Clinical Oncology
  • "Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up" (2020), published in Annals of Oncology
  • "Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline" (2021), published in Journal of Clinical Oncology
  • "Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial" (2022), published in The Lancet Oncology
  • "Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy" (2020), published in Annals of Oncology

The scientist has collaborated extensively with several frequent co-authors, including Brigette Ma, Edwin P. Hui, Kenneth C.W. Wong, W.K. Lam, and Ann D. King.

Publication venues associated with this researcher highlight a concentration in oncology and clinical research, featuring multiple works in the following journals:

  • Annals of Oncology
  • Journal of Clinical Oncology
  • Cancer Research
  • Nature Reviews Clinical Oncology
  • The Lancet Oncology

In addition to journal articles, Anthony T.C. Chan has contributed to book publications. One identified work, published by Springer International Publishing in 2023, is titled Immunotherapy for Head and Neck Cancer.

Best Publications

  • Quantitative Analysis of Cell-free Epstein-Barr Virus DNA in Plasma of Patients with Nasopharyngeal Carcinoma

    Y. M.Dennis Lo;Lisa Y.S. Chan;Kwok Wai Lo;Sing Fai Leung

  • Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients

    Bertrand Baujat;Hélène Audry;Jean Bourhis;Anthony Tak-cheung Chan

  • Prospective Randomized Study of Intensity-Modulated Radiotherapy on Salivary Gland Function in Early-Stage Nasopharyngeal Carcinoma Patients

    Michael K.M. Kam;Sing Fai Leung;Benny Zee;Ricky M.C. Chau

  • A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.

    Winnie Yeo;Tony S. Mok;Benny Zee;Thomas W. T. Leung

  • Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective

    Anne W.M. Lee;Brigette B.Y. Ma;Wai Tong Ng;Anthony T.C. Chan

  • Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis

    Pierre Blanchard;Pierre Blanchard;Anne Lee;Sophie Marguet;Julie Leclercq

  • Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.

    Michael K.M. Kam;Peter M.L. Teo;Ricky M.C. Chau;K. Y. Cheung

  • Overall Survival After Concurrent Cisplatin-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma

    Anthony Tak-cheung Chan;Sing-fai Leung;Roger K.C. Ngan;Peter M.L. Teo

  • Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer.

    K C Allen Chan;John K S Woo;Ann King;Benny C Y Zee

  • Randomized Phase II Trial of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Docetaxel and Cisplatin in Advanced Nasopharyngeal Carcinoma

    Edwin P. Hui;Brigette B. Ma;Sing F. Leung;Ann D. King

  • Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial

    A.T.C. Chan;P.M.L. Teo;R.K. Ngan;T.W. Leung

  • Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing

    K. C.Allen Chan;Peiyong Jiang;Yama W.L. Zheng;Gary J.W. Liao

  • Adjuvant intra-arterial lipiodol-iodine-131 for resectable hepatocellular carcinoma: a prospective randomised trial

    W. Y. Lau;T. W.T. Leung;S. K.W. Ho;M. Chan

  • Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers

    Vincent Wai Sun Wong;Stephen Lam Chan;Frankie Mo;Tung Ching Chan

  • Quantitative and Temporal Correlation between Circulating Cell-Free Epstein-Barr Virus DNA and Tumor Recurrence in Nasopharyngeal Carcinoma

    Y. M. D. Lo;L. Y. S. Chan;A. T. C. Chan;S.-F. Leung

  • Plasma Epstein-Barr Virus DNA and Residual Disease After Radiotherapy for Undifferentiated Nasopharyngeal Carcinoma

    Anthony T C Chan;Y. M Dennis Lo;Benny Zee;Lisa Y S Chan

  • Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing

    K. C. Allen Chan;Peiyong Jiang;Carol W. M. Chan;Kun Sun

  • Molecular Prognostication of Nasopharyngeal Carcinoma by Quantitative Analysis of Circulating Epstein-Barr Virus DNA

    Y. M. Lo;Anthony T. C. Chan;Lisa Y. S. Chan;Sing-Fai Leung

  • Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.

    Edwin Pun Hui;Anthony Tak-cheung Chan;Francesco Pezzella;Helen Turley

  • Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments.

    Qian Tao;Anthony Tak-cheung Chan

Frequent Co-Authors

Winnie Yeo
Winnie Yeo Chinese University of Hong Kong
Philip J. Johnson
Philip J. Johnson University of Liverpool
Qian Tao
Qian Tao Chinese University of Hong Kong
Tony Mok
Tony Mok Chinese University of Hong Kong
Benny Chung-ying Zee
Benny Chung-ying Zee Chinese University of Hong Kong
Stephen L. Chan
Stephen L. Chan Chinese University of Hong Kong
Y.M. Dennis Lo
Y.M. Dennis Lo Chinese University of Hong Kong
Ka-Fai To
Ka-Fai To Chinese University of Hong Kong
Paul B.S. Lai
Paul B.S. Lai Chinese University of Hong Kong
Sai Wah Tsao
Sai Wah Tsao University of Hong Kong

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to many online degrees and career options for aspiring healthcare professionals. Flexible study formats and accelerated programs help students achieve their goals, even when balancing work and personal commitments.

For those interested in advanced nursing leadership, consider dnp programs without dissertation. These offer a streamlined route to a Doctor of Nursing Practice without a lengthy research project. If you want to gain nursing experience quickly, 6 month lpn program online options provide a fast track into practical nursing roles.

Specializing in mental health is another rewarding pathway; the fastest psych np program helps you become a psychiatric nurse practitioner in less time than traditional programs. Alternatively, if you’re drawn to healthcare operations, healthcare administration degrees prepare you for career advancement in hospital or clinical leadership.

These online degrees are ideal for those seeking flexibility, career growth, and specialized knowledge within the diverse field of medicine in the USA.

Best Scientists Citing Anthony T.C. Chan

Trending Scientists